MedPath

Dexmedetomidine in Sonographic Guided Erector Spinae Plane Block

Phase 2
Recruiting
Conditions
Pain Management
Interventions
Registration Number
NCT06899841
Lead Sponsor
Assiut University
Brief Summary

to investigate the postoperative analgesic effect of dexmedetomidine addition with different doses as an adjuvant to bupivacaine to Erector spinae plane block after renal surgeries.

Detailed Description

Not available

Recruitment & Eligibility

Status
RECRUITING
Sex
All
Target Recruitment
90
Inclusion Criteria
  • Age between 18 and 70 years.
  • Both sexes, males and females.
  • Patients with the American Society of Anesthesiologists (ASA) physical status I/II.
  • Body mass index (BMI) of 18-35 kg/m2
  • Patients scheduled for elective Renal or Percutaneous Nephrolithotomy.
Exclusion Criteria
  • Patients under 18 years.
  • Patient refusal of nerve block.
  • Infection at the site of injection.
  • Coagulopathy.
  • Allergy to used medications.
  • Psychiatric disorder or chronic pain syndromes.
  • Chronic opioid use or substance abuse.
  • Quadriplegic patients.

Study & Design

Study Type
INTERVENTIONAL
Study Design
PARALLEL
Arm && Interventions
GroupInterventionDescription
low dose dexDexmedetomidine0.5 mic/kg of dexmedetomidine administered
high dose dexDexmedetomidine1 mic/kg of dexmedetomidine administered
intermediate dose dexDexmedetomidine0.75 mic/kg of dexmedetomidine administered
Primary Outcome Measures
NameTimeMethod
postoperative analgesic duration24 hours

postoperative analgesic duration with each dose

Secondary Outcome Measures
NameTimeMethod
Pain score24 hours

severity of pain using visual analogue pain score

side effects24 hours

as hemodynamic effect as (hypotension, bradycardia), nausea and vomiting.

dynamic pain score24 hours

Dynamic visual analogue pain score (pain with cough, deep breath, and movement)

Trial Locations

Locations (1)

Assiut University Hospitals

🇪🇬

Assiut, Assiut Governorate, Egypt

© Copyright 2025. All Rights Reserved by MedPath